| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US7553863 | PAR PHARM INC | Ultrapure 4-methylpyrazole |
Jun, 2027
(3 years from now) | |
Antizol is owned by Par Pharm Inc.
Antizol contains Fomepizole.
Antizol has a total of 1 drug patent out of which 0 drug patents have expired.
Antizol was authorised for market use on 04 December, 1997.
Antizol is available in injectable;injection dosage forms.
The generics of Antizol are possible to be released after 30 June, 2027.
Drugs and Companies using FOMEPIZOLE ingredient
Market Authorisation Date: 04 December, 1997
Treatment: NA
Dosage: INJECTABLE;INJECTION
How can I launch a generic of ANTIZOL before it's drug patent expiration?
More Information on Dosage
ANTIZOL family patents
